As a result, IL-2 (P = 0.008) and IL-4 (P = 0.027) were statistically significantly lower in acral melanoma patients than non-acral melanoma patients, and the results showed no statistically significant difference in other cytokines. This evidence concerns the gene IL2 and acral lentiginous melanoma.